The New York City Department of Environmental Protection surveyed your risk of being exposed to asbestos in buildings. They looked at 886 buildings from 16…
Read MoreFirm News: Drugs & Devices: Page 2
Category: Consumer, Drugs & Devices
W&L and Co-Counsel Reach $235M Settlement in Altria E-Cig Youth Vaping Crisis
Weitz & Luxenberg and co-lead counsel are pleased to announce a historic $235 million settlement with defendant Altria Group, Inc., in the federal multidistrict…
Category: Drugs & Devices
W&L Exactech Recalled Hip and Knee Implants Lawsuits Move Forward
Weitz & Luxenberg attorneys Ellen Relkin and Danielle Gold continue to lead efforts against Exactech due to recalled hip and knee implant failures. The…
W&L Attorneys Present at NJAJ Boardwalk Seminar 2023
Weitz & Luxenberg has a long-standing tradition of participating in critical legal learning opportunities. This spring is no different. Several of our attorneys are…
Category: Consumer, Drugs & Devices
W&L Investigating Recalled Contaminated Eye Drops Due to Blindness and Death
Weitz & Luxenberg is investigating claims that using EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears can lead to blindness or death. The manufacturer,…
W&L Attorney Garcia Appointed to Hair Relaxer Products MDL Leadership
Attorney EricaRae Garcia has been appointed to serve on the Plaintiffs' Steering Committee (PSC) in the multidistrict litigation (MDL) involving hair relaxers that cause…